Home > > Global OTC Drug and Dietary Supplement Market Report
The OTC Drug and Dietary Supplement market was valued at $327,513.2 Million in 2023, and is projected to reach $455,819.9 Million by 2030 growing at a CAGR of 4.90% from 2024 to 2030. Vitamins and Supplements segment is expected to be the highest contributor to this market, with $88,679.9 Million in 2023, and is anticipated to reach $126,462.9 Million by 2030, registering a CAGR of 5.26%. Dermatological Products segment is anticipated to reach $84,584.3 Million by 2030 with the highest CAGR of 5.54%. Vitamins and Supplements and Dermatological Products segments collectively expected to account for about 44.9% share of the OTC Drug and Dietary Supplement market in 2023, with the former constituting around 27.1% share. Dermatological Products and Vitamins and Supplements segments are expected to witness significant growth rates at a CAGR of 5.54% and 5.26% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 44.9% in the overall OTC Drug and Dietary Supplement market in 2023, and is anticipated to reach 46.3% by 2030. Category Analgesics Dermatological Products Gastrointestinal Products Vitamins and Supplements Opthalmic Products Other Categories Form Tablets Capsules Powder Gummies Softgels Liquid Product Branded Drugs Generic Drugs Distribution Channel Pharmacies Supermarkets Vitamin and Health Food Stores Online Pharmacy Other Distribution Channels BY REGION North America US Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan Indonesia India South Korea Rest of Asia Middle East & Africa Brazil Mexico South Africa Rest of MENA